FindTrial
Sign In

Role of Emesis in Treatment of Thyroid Disease

A Clinical Study to Evaluate the Effect of Vamana Karma in Auto Immune Hypothyroidism - An Open Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019735
Enrollment
15
Registered
2019-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

Intervention1: Vamana (Emesis Treatment): The Patient will be administered with Madanaphala once dose will be of 5gms orally only one time. Total duration one day Control Intervention1: Not Applicable

Sponsors

Dr Shawn Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of Hypothyroidism Patients known case of hypothyroidism and on Thyroxine Therapy Patients with TSH Levels of > 4.5mIU/L (AACE) (8) Raised anti- TPO values of >35 IU/L (8) The age group of 20 to 60 years old Patient of Subclinical Hypothyroidism

Exclusion criteria

Exclusion criteria: Vamana Ayogya Patient Patients with complications of hypothyroidism like Cardiac Disease, Coma, Cancer, and Myxedema Pregnant or Lactating Women Patients suffering from Major Systemic illness

Design outcomes

Primary

MeasureTime frame
Vamana Karma done with Varunadi Ghrita turns out to be more efficacious in decreasing the Thyroid antibodiesTimepoint: 0th, 8th, 30th day—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr B S Prasad

KAHERs Shri B.M.K. Ayurveda Mahavidyalaya

shawnskywalker250@gmail.com9583607773

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026